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Abstract
The psychological impact of the Covid 19 pandemic on cancer patients, a population at
higher risk of fatal consequences if infected, has been only rarely evaluated. This study was
conducted at the Departments of Oncology of four hospitals located in the Verona area in
Italy to investigate the psychological consequences of the pandemic on cancer patients
under active anticancer treatments. A 13-item ad hoc questionnaire to evaluate the psycho-
logical status of patients before and during the pandemic was administered to 474 consecu-
tive subjects in the time frame between April 27th and June 7th 2020. Among the 13
questions, 7 were considered appropriate to elaborate an Emotional Vulnerability Index
(EVI) that allows to separate the population in two groups (low versus high emotional vulner-
ability) according to observed median values. During the emergency period, the feeling of
high vulnerability was found in 246 patients (53%) and was significantly associated with the
following clinical variables: female gender, being under chemotherapy treatment, age� 65
years. Compared to the pre-pandemic phase, the feeling of vulnerability was increased in
41 patients (9%), remained stably high in 196 (42%) and, surprisingly, was reduced in 10
patients (2%). Overall, in a population characterized by an high level of emotional vulnerabil-
ity the pandemic had a marginal impact and only a small proportion of patients reported an
increase of their emotional vulnerability.
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Introduction
On December 2019, an outbreak of novel coronavirus disease (COVID-19) occurred in
Wuhan, linked to the severe adult respiratory syndrome coronavirus 2 (SARS-CoV-2). It is
characterized by rapid human to human transmission from droplet contamination [1, 2]. The
infection spread from China to Europe and to the rest of the world, becoming rapidly pan-
demic; as of June 21st 2020, the World Health Organization reported 8,708,008 confirmed
cases, with 461,715 deaths, world-wide.
In Europe, Italy was severely hit, especially the Lombardia and bordering regions such Pie-
monte, Emilia Romagna and Veneto, with 238,275 cases and 34,610 deaths reported, repre-
senting a global share of 2.7% and 7.5% for incidence and mortality, respectively [3].
To contrast the infection the Italian Government issued a series of ordinances gauged on
the risk of infection. In phase 1 (from March 9th to May 3rd) [4] a general lockdown was
enforced, during which most industrial and commercial activities were suspended and peo-
ple were asked to stay at home and to leave home only to satisfy primary needs (to buy food,
personal hygiene items, house cleaning supplies, etc); the majority of hospitals, especially in
Northern Italy, became hostages of the pandemia and many patients died leaving a strong
impact not only to sick people but to the entire population. In this catastrophic emergency
the health system had to adapt to meet the needs of patients infected, quite often very sick,
while maintaining essential healthcare for all. Furthermore, emphasis was put on the need
to ensure essential care for patients with cancer, a potentially frailer fringe of the popula-
tion, exposed to both a higher risk of COVID-19 and fatal consequences [5–7]. During the
following phases (phase 2 from May 04th to June 14th and phase 3 which started on June
15th) industrial and commercial activities were gradually reopened and people regained
their right to move, but still respecting some rules such as physical distancing and wearing a
facial mask.
Given the high infection rate of SARS-Cov-2, activities in favor of cancer patients were
remodulated to ensure that patients were not exposed to COVID-19. Face-to-face consulta-
tions were, whenever possible, taking place via web consulting or by telephone calls.
Patients with non-urgent appointments that would require them to be physically present in
the hospital for routine and follow-up visits or surgeries would be postponed as often as
possible. In addition, the centers did not allow visitors or caregivers to accompany their
loved ones when admitted to the hospital for infusions or radiation treatment, as visitors
could potentially be (unknowingly) COVID-19 positive. Patients with mild symptoms con-
sistent with COVID-19 were told not to come for their appointments and to follow national
guidance on isolation and/or quarantine [8, 9].
These directives were taken very seriously by patients and by mid-April 2020 the decision
to keep away from the hospital all the cancer patients not in need of active therapy resulted in
a reduction not only of visits (estimated around 15–20%) but also in a drop in the number of
new diagnosis of solid tumors in the same range [10–12].
Research on the psychological impact of COVID-19 on cancer patients is still sparse,
but it is conceivable that this pandemic should have a negative impact on the feeling of
vulnerability in this population, although a recent study showed that when cancer patients
are supported by a health care team which includes psychologists experience a better qual-
ity of life [13].
This study was planned to investigate the psychological consequences of the current pan-
demic on patients dealing with a serious oncological disease and under active anticancer treat-
ments at the Departments of Oncology of the University Hospital of Verona and of the Health
Maintenance Organization “Scaligera” of the Veneto Region, in Northern Italy.
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Methods
Study design and participants
This prospective study was conducted at the Departments of Oncology of the University Hos-
pital in Verona and at the Department of Oncology of the Health Maintenance Organization
“Scaligera” of the Veneto Region (which includes the Cancer Centers of the Hospitals in Leg-
nago, San Bonifacio and Villafranca). Clinical data were retrospectively retrieved from the
medical records, including demographic and clinical characteristics. This study was approved
by the Ethics Committee of Verona and Rovigo Provinces on April 16th 2020 and all the
enrolled patients signed a written inform consent, no minors have been included in the study.
Overall 474 questionnaires were administered. For each patient, sociodemographic charac-
teristics (age, gender, marital, education and occupancy status) and cancer history (primary
tumor diagnosis, stage, line, setting, type of therapy and performance status) were collected.
Scoring of COVID-19 psychological impact
The psychosocial impact of Covid-19 on patients affected by solid and hematologic malignan-
cies under active treatments was evaluated through a 13-item ad hoc questionnaire (Table 1)
prepared by the clinical Psychologists of our group and submitted to patients by staff members
in the time frame between April 27th and June 7th.
For questions 1 and 2 the answers could be Yes/No while for questions 3–13 the answers
could fall in a 4-point Likert scale in which 1 and 2 means “not at all, a little” while 3–4 means
“quite, a lot”; for questions 3 to 13 patients were asked to give a score to their feeling before
and during the pandemic. Furthermore, among the 13 questions, psychologists identified the
seven questions included from n. 3 to n. 9 as crucial for the classification of emotional vulnera-
bility (i.e. main anxiety /depression symptoms). By summing the scores given by the patient to




1 Did you result positive to the Covid 19 test?
2 Did a member of your family or a friend result positive to the Covid 19 test?
3 How much do you feel anxious/worried for your cancer?(before and during the pandemia)
4 How much do you feel sad/discouraged for your cancer? (before and during the pandemia)
5 How much do you feel fragile/vulnerable for your cancer?(before and during the pandemia)
6 Are you pessimistic about the cure of your cancer? (before and during the pandemia)
7 How much do you feel disoriented/confused about the management of your cancer? (before and
during the pandemia)
8 How much the concerns about your cancer influence the quality of your sleep?
9 Do you feel pleasure for actions you have always enjoyed?
10 How much do you feel supported/helped in dealing with your cancer by your family members?
11 How much do you feel supported/helped in dealing with your cancer by the staff of the oncology
center?
12 Overall, in this situation of generalized hardship due to Covid 19 emergency do you feel your
discomfort increase?
13 How much the Covid 19 emergency influences the management of your cancer
For questions 1 and 2 the answers could be Yes/No; for questions 3–13 the answers could be graded according to a
numeric scale 1–2 (not at all, a little); 3–4 (quite, a lot) and patients were asked to score their feelings before and
during the pandemic.
https://doi.org/10.1371/journal.pone.0248714.t001
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each of these questions a Emotional Vulnerability Index (EVI) was obtained (score range
7–28). Scores were classified on the basis of the median grade: low EVI< median; moderate/
high� the median. To investigate the impact of the Covid 19 pandemic on the psychological
status of patients the respondents were classifieds in 4 categories according to the observed
median value: low/low (score < the median value pre and during Covid19 outbreak), low/high
(score < the median value pre,� the median value during Covid19 outbreak), high/low
(score� the median value pre,< the median value during Covid19 outbreak), high/high
(score� the median value pre and during). The quartile distribution of the scores pre and dur-
ing the pandemic is shown in Fig 1.
Statistical analysis
For descriptive analysis, variables are presented as number and percentage (%). We used the
Chi-square test (significance α = 0,05) to evaluate whether there was any correlation between
clinic-demographic factors and the EVI among oncological patients. Clinical and demographic
factors included were age (18–65 and over 65), gender, Performance status (ECOG 0–1 versus
2 or higher), stage (I-III versus IV), therapy setting (neo-adjuvant/adjuvant versus metastatic),
therapy line (front line versus subsequent), type of therapy (chemotherapy versus biologicals)
and the pandemic organizational phase (phase 1 versus phase 2).
Results
Demographic and clinical characteristics
Overall, 474 patients were enrolled and completed individual questionnaires. Twelve question-
naires were incompletely filled. Table 2 lists the main clinical and demographic characteristics
of patients.
The majority of patients were female (309, 65%) and median age was 62 (20–97). Three
hundred and seventy eight patients (80%) were married or in a domestic partnership, forty
three (9%) were single, forty (8%) were widowed and thirteen (3%) were divorced/separated.
The majority of enrolled patient (174, 37%) held a university degree, 138 (29%) have a high
school diploma, one hundred and five (22%) have a primary school diploma while the remain-
ing fifty seven (12%) did not go beyond the elementary school.
Fig 1. Types of cancers among the included patients.
https://doi.org/10.1371/journal.pone.0248714.g001
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Among respondents, the most common oncological diagnoses were breast cancer (190
patients, 40%), lung cancer (61 patients, 13%), pancreatic cancer (61 patients, 13%), colorectal
cancer (41 patients, 8%), hematologic malignancies (31 patients, 6%), gynecologic cancer (24
patients, 5%), prostate cancer (18 patients, 4%), stomach cancer (15 patients, 3%), head and
neck cancer (13 patients,3%), kidney cancer (8 patients, 2%) and other such melanoma, sar-
coma and testicular cancer (11 patients, 3%) (Fig 1).
Metastatic disease (stage IV) was the most prevalent condition (229 patients, 48%); chemo-
therapy was the prevalent type of treatment for the majority of patients(291, 61%); targeted
therapy was given to 109 patients (23%), while 47 patients (10%), 14 patients (3%) and 13
patients (3%) were receiving immunotherapy, radiotherapy or endocrine therapy, respectively.
Questionnaire results
No patient reported Covid 19 positivity, while 11 of their relatives had had a positive test. The
vast majority of patients reported a strong family support (question n. 10), with 429 subjects
(90%) grading such support as “quite/a lot”. Similar results were obtained regarding support
received by cancer center healthcare providers, graded as 3–4 by 90% of patients. However, the
situation of generalized hardship due to the Covid 19 emergency increased the patient’s dis-
comfort “quite/a lot” (question n. 12) in a sizable number of patient (165, 35%). Regarding the
Emotional Vulnerability Index, the results for the pre-emergency period show low level of emo-
tional distress. In fact only a minority of patients (187, 39%) gave on average to these questions
a 3–4 score meaning that they were not able to cope with their cancers (Table 3).
The EVI increased during the pandemic to 210 (44%). An evaluation of each single item
shows a certain degree of variability in the number of patients who gave a high score, from as
low as 16% for the feeling of disorientation/confusion felt in the pre-pandemic phase (increased
to 22% during the pandemic phase) to as high as 77% in the pre-pandemic phase (decreased to
73% during the pandemic phase) for the “lack of interest/pleasure”. Fig 2 shows the quartile
distribution of the casuistic.
Some degree of variability of the feeling of EVI was observed across the tumor types with
the majority of breast cancer patients (56%) presenting a high score of vulnerability; this pro-
portion falls among prostate (28%) and stomach (27%) cancers (Fig 3).
During the emergency period the feeling of low vulnerability remained stable for 216 (47%)
while for 41 patients (9%) there was an increase. In 196 patients (42%) the feeling of vulnera-
bility remained stably high and, surprisingly enough, in 10 patients (2%) their feeling of vul-
nerability was reduced.
Among the clinical characteristics (age, gender, ECOG performance status, clinical stage,
therapy setting, therapy line, type of anticancer therapy) investigated in patients who were vul-
nerable in the pre-pandemic phase the only two who retained a statistically significant
Table 3. Variables for EVI evaluation pre and during the emergency period.
Variable Pre (%) During (%)
Anxiety/worry 224 (48) 263 (57)
Sadness/ discouragement 191 (41) 225 (49)
Fragility/vulnerability 179 (39) 216 (47)
Pessimism 139 (30) 153 (33)
Disorientation/confusion 77 (17) 106 (23)
Worsening of the quality of sleep 135 (29) 165 (36)
Lack of interest/pleasure 364 (79) 344 (74)
https://doi.org/10.1371/journal.pone.0248714.t003
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association with the likelihood of emotional vulnerability were female gender and chemother-
apy (Table 4).
Table 5 depicts the correlations of the feeling of vulnerability with the above mentioned
variables during the Covid 19 pandemic in two hundred and forty six patients (53%) and
shows that female gender and chemotherapy retained a significant association with the feeling
of emotional vulnerability together with a young age (� 65 years).
Female gender was the only variable to show a statistically significant association with the
feeling of emotional vulnerability among the 41 patients whose feeling of vulnerability
increased during the pandemic (Table 6).
The ten patients who presented a reduction of the feeling of emotional vulnerability from
high to low during the pandemic have an age ranging from 40 to 67 year (median 56) are
mainly female (8/10) and are affected by breast cancer (4 patients) lung cancer (3 patients)
Fig 2. Quartile distribution of the casuistic.
https://doi.org/10.1371/journal.pone.0248714.g002
Fig 3. Emotional Vulnerability Index (EVI) and type of cancers.
https://doi.org/10.1371/journal.pone.0248714.g003
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ovarian, uterine and prostate cancer (one patient) treated with chemotherapy (6 patients),
immunotherapy (3 patients) and target therapy (1 patient).
Finally, since it is conceivable that during phase 1 the EVI, could be higher than during the
following phases, the 65 questionnaires (14%) collected during this phase (April 27th–May
03rd) were analyzed separately from the remaining 409 (86%) collected during Phase 2 (May
04th–June 07th) and the results show that during phase 1 patients were more likely to undergo
the worsening of their vulnerability (10/65, 15.4%, as compared to 32/409, 0.8%; p = 0.006).
Discussion
Cancer is a complex disease which encompasses several entities associated with peculiar biol-
ogy, clinical history and evolution, stage at presentation and prognosis. Although it is usually
difficult to convey all the complexity of the disease in normal situation the task can become
overwhelming in a catastrophic situation such the Covid 19 pandemic when the idea that “can-
cer patients” in general are at a very high risk of severe complications and possibly of death, if
infected, is widespread. Patients worry not only for the risk of getting infected but are also con-
cerned of a possible neglect of their cure by a health system engulfed with Covid 19 patients. In
this scenario the ability of patients to cope with the disease can be impaired and increased sup-
port by health personnel might be needed.
In this study involving a significant number of cancer patients under active treatment for
different types of solid and hematologic cancers we wanted to study the impact of the Covid 19
pandemic on their “basal” psycho-social state through the administration of a simple question-
naire in which patients were asked to describe whether their feelings were changed in the “dur-
ing the pandemic” period, as compared to the “pre-pandemic” period. We acknowledge that
Table 4. Correlation between clinical variables and patients’ vulnerability in the pre-pandemic period.
PRE (SCORE� 15)
Clinical variables N. total N. of vulnerable Proportion (IC 95%) P-value
AGE
�65 282 140 0.496 (0.439–0.554) N.S.
>65 180 75 0.417 (0.347–0.490)
GENDER
Female 301 157 0.552 (0.465–0.577) 0.000923
Male 161 58 0.360 (0.290–0.437)
PERFORMANCE STATUS (ECOG)
0–1 433 199 0.460 (0.413–0.507) N.S.
�2 29 16 0.552 (0.376–0.715)
STAGE
I-III 242 116 0.479 (0.417–0.542) N.S.
IV 220 99 0.450 (0.386–0.516)
THERAPY SETTING
Neoadjuvant/Adjuvant 242 116 0.479 (0.417–0.542) N.S.
Metastatic 220 99 0.450 (0.386–0.516)
THERAPY LINE
First line 121 52 0.430 (0.345–0.519) N.S.
Subsequent lines 99 47 0.475 (0.379–0.572)
ANTICANCER THERAPY
Chemotherapy 291 140 0.481 (0.424–0.538) 0.000152
Biologicals 156 44 0.282 (0.217–0.358)
https://doi.org/10.1371/journal.pone.0248714.t004
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this method of survey brings the risk of recall bias. In fact the best way to conduct the survey
would be through the administration of the same questionnaire before and during the pan-
demic but unfortunately the speed and the degree of destruction brought about by the pan-
demic did not allow this kind of evaluation.
Instead of evaluating the results of the questionnaires according to pre-defined scores,
chosen arbitrarily, we decided to discriminate the level of “emotional vulnerability” shown
by patients on the base of the observed median value of the score. As a result, we obtained
two group of patients of almost the same consistency with a tiny majority of patients (247,
53%) falling in the low-score group and the remaining patients (215, 47%) falling in the
high score group. Among the patients who are more vulnerable in a “basal” situation the
clinical characteristic which showed a statistically significant association with the vulnera-
bility are female gender and type of therapy (chemotherapy compared with other treat-
ments). The questionnaires showed that this feeling of vulnerability increased during the
pandemic in 41 patients and decreased in ten patients. As a results the patients vulnerable
during the pandemic are 246 and again are more likely to be female and to be on treatment
with chemotherapy. In this group the new variable age emerges as statistically significant,
with patients � 65 years being more emotionally vulnerable. The only clinical characteris-
tic associated with the increased of the feeling of vulnerability in a statistically significant
matter among the 41 patients who became more vulnerable during the pandemic is female
gender.
The observation that female patients are more vulnerable is in line with results from several
authors, suggesting an assumption of women’s higher vulnerability to the effects of stressful
life events [14–17]. It is also conceivable that chemotherapy, more toxic compared to other
Table 5. Correlation between clinical variables and patients’ vulnerability during the pandemic period.
DURING (SCORE� 15)
Clinical variables N. total N. of vulnerable Proportion (IC 95%) P-value
AGE
�65 282 161 0.553 (0.513–0.627) 0.038126
>65 180 85 0.472 (0.401–0.545)
GENDER
Female 301 184 0.611 (0.555–0.665) 0,0000034
Male 161 62 0.385 (0.314–0.462)
PERFORMANCE STATUS (ECOG)
0–1 433 230 0.535 (0.484–0.578) N.S.
�2 29 16 0.552 (0.376–0.715)
STAGE
I-III 242 135 0.558 (0.495–0.619) N.S
IV 220 111 0.505 (0.439–0.570)
THERAPY SETTING
Neoadjuvant/Adjuvant 242 135 0.558 (0.495–0.619) N.S
Metastatic 220 111 0.505 (0.439–0.570)
THERAPY LINE
First line 121 59 0.488 (0.400–0.576) N.S
Subsequent lines 99 52 0.525 (0.428–0.621)
ANTICANCER THERAPY
Chemotherapy 291 159 0.546 (0.489–0.603) 0.012938
Biologicals 156 66 0.423 (0.348–0.502)
https://doi.org/10.1371/journal.pone.0248714.t005
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forms of anti-cancer treatment present a heavier impact on the feeling of emotional vulnerabil-
ity shown by patients.
In this study the psychological consequences of the pandemic were better handled by
patients of 65 years of age or older, in line with previous reports showing that older cancer
patients may present less psychological distress than younger patients [18–20].
The negative influx of the pandemia on the vulnerability is corroborated by the observation
that questionnaires administered during the phase 1, the closest to the phase of lockdown with
its corollary of daily bad news and video of military trucks transporting dead bodies to the
incineration facilities, were more likely to pick up an increased feeling of distress. Unfortu-
nately, the study could be performed only in the final phases of the pandemic and this is for
sure a point of weakness.
In conclusion, the pandemic did have an impact on the feeling of vulnerability shown by
cancer patients especially among patients of female gender, patients 65 year old or younger






Table 6. Correlation between clinical variables and the increase of vulnerability during the pandemic period.
LOW to HIGH
Clinical variables N. total N. of vulnerable Proportion (IC 95%) P-value
AGE
�65 282 28 0.099 (0.069–0.140) N.S.
>65 180 13 0.072 (0.042–0.121)
GENDER
Female 301 33 0.110 (0.079–0.151) 0.030856
Male 161 8 0.050 (0.024–0.097)
PERFORMANCE STATUS (ECOG)
0–1 433 40 0.068 (0.068–0.124) N.S.
�2 29 1 0.034 (0.000–0.189)
STAGE
I-III 242 27 0.112 (0.078–0.158) N.S.
IV 220 14 0.064 (0.038–0.105)
THERAPY SETTING
Neoadjuvant/Addjuvant 242 27 0.112 (0.078–0.158) N.S.
Metastatic 220 14 0.064 (0.038–0.105)
THERAPY LINE
First line 121 8 0.066 (0.032–0.128) N.S.
Subsequent lines 99 6 0.061 (0.026–0.129)
ANTICANCER THERAPY
Chemotherapy 291 30 0.103 (0.073–0.144) N.S.
Biologicals 156 9 0.058 (0.030–0.108)
https://doi.org/10.1371/journal.pone.0248714.t006
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